Immune Pharmaceuticals Inc. (Nasdaq: IMNP) announced that it has entered into an amended agreement with NPT, a syndicate of experienced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE